✦ LIBER ✦

Plasma Clozapine Levels and the Treatment of L-DOPA-Induced Psychosis in Parkinson's Disease A High Potency Effect of Clozapine

✍ Scribed by Meltzer, H

Book ID: 123212124
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 727 KB
Volume: 12
Category: Article
ISSN: 1470-634X
DOI: 10.1016/0893-133X(94)00060-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clozapine for the treatment of levodopa-

Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease

✍ Stephen H. Rosenthal; Martin L. Fenton; David S. Harnett 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Clozapine for the treatment of psychosis

Clozapine for the treatment of psychosis in Parkinson's disease: a review

✍ P. Auzou; C. Özsancak; D. Hannequin; N. Moore; P. Augustin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

Treatment of drug-induced psychosis in P

Treatment of drug-induced psychosis in Parkinson's disease with clozapine: a case report

✍ Courtet, P.; Abbar, M.; Caer, Y.; Castelnau, D. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 96 KB

To: Treatment of drug-induced psychosis

To: Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease

📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 90 KB

Clozapine replacement by quetiapine for

Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Margaret C. Lannon; Joseph H. Friedman; Bruce P. Abbott 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

Cases of delayed or acute posttraumatic, therapy-resistant tremor have been previously described. [1][2][3][4] The onset is usually delayed (weeks to months/years), but they may also begin rapidly (within hours). Careful neuroradiologic examination may reveal small lesions, often in the deep brain a

The effects of cisapride on plasma L-dop

The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease

✍ Walter Diaz Neira; Vicenta Sanchez; Maria Angeles Mena; Dr. Justo Garcia de Yebe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

Cisapride (CIS) is a prokinetic agent that increases gastrointestinal motility in normal individuals and improves constipation in Parkinson's disease (PD). We studied the effects of CIS on the clinical response and the peripheral pharmacokinetics of orally administered L-dopa given to patients with